Decreased CRTH2 Expression and Response to Allergen Re-stimulation on Innate Lymphoid Cells in Patients With Allergen-Specific Immunotherapy

다국어 초록 (Multilingual Abstract)

Purpose: Group 2 innate lymphoid cells (ILC2s) have been implicated in the pathogenesis of allergic disease. However, the effect of allergen-specific immunotherapy (AIT) on ILCs remains to be clarified. The aim of this study was to evaluate the levels of ILC subsets in allergic rhinitis (AR) patients in response to house dust mite (HDM)-specific immunotherapy.
Methods: We enrolled 37 AR patients undergoing AIT (16 responders and 11 non-responders) for 2 years, 35 HDM AR patients and 28 healthy subjects. Peripheral blood mononuclear cells (PBMCs) were analyzed by flow cytometry to identify ILC subsets. Stimulation of ILC2s with recombinant allergen-specific protein was used to determine ILC2's activation (CD69 expression).
Results: Responder AIT patients and healthy subjects had a decreased frequency of circulating ILC2s compared to non-responder AIT and AR patients. Conversely, ILC1s from responder AIT patients and healthy subjects showed increased frequency compared to non-responder AIT and AR patients. The frequency of ILC3s natural cytotoxicity receptor (NCR)+ and NCR− in responder AIT patients was significantly lower compared to AR patients and healthy subjects. The ILC1: ILC2 proportion in responder AIT patients was similar to that of healthy subjects. PBMCs from patients who were responders to AIT had a significantly lower expression of the activation marker CD69 on ILC2s in response to allergen re-stimulation compared to AR patients, but no difference compared to non-responder AIT patients and healthy subjects.
Conclusions: We propose that AIT might affect ILC responses. The activation of ILC2s was reduced in AR patients treated with AIT. Our results indicate that a relative ILC1/ILC2 skewed response is a possible key to successful AIT.

참고문헌 (Reference)

1 Liu T, "Type 2 innate lymphoid cells: a novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma" 109 : 1391-1396, 2015

2 Nagakumar P, "Type 2 innate lymphoid cells in induced sputum from children with severe asthma" 137 : 624-626.e6, 2016

3 Sugita K, "Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients" 141 : 300-310.e11, 2018

4 Rigas D, "Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction" 139 : 1468-1477.e2, 2017

5 Mjösberg J, "The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells" 37 : 649-659, 2012

6 Price AE, "Systemically dispersed innate IL-13-expressing cells in type 2 immunity" 107 : 11489-11494, 2010

7 Fan DC, "Suppression of Immunotherapy on group 2 innate lymphoid cells in allergic rhinitis" 129 : 2824-2828, 2016

8 Lao-Araya M, "Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy" 134 : 1193-1195.e4, 2014

9 Cosmi L, "Role of type 2 innate lymphoid cells in allergic diseases" 17 : 66-, 2017

10 Marcin Wawrzyniak, "Role of Regulatory Cells in Oral Tolerance" 대한천식알레르기학회 9 (9): 107-115, 2017

11 Caraballo L, "Particularities of allergy in the Tropics" 9 : 20-, 2016

12 Xu G, "Opposing roles of IL-17A and IL-25 in the regulation of TSLP production in human nasal epithelial cells" 65 : 581-589, 2010

13 Kato Y, "Nasal sensitization with ragweed pollen induces local-allergic-rhinitis-like symptoms in mice" 9 : e103540-, 2014

14 von Burg N, "Maintenance of immune homeostasis through ILC/T cell interactions" 6 : 416-, 2015

15 Halim TY, "Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation" 36 : 451-463, 2012

16 Fuchs A, "Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells" 38 : 769-781, 2013

17 Wise SK, "International consensus statement on allergy and rhinology: allergic rhinitis" 8 : 108-352, 2018

18 Moro K, "Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells" 463 : 540-544, 2010

19 Spits H, "Innate lymphoid cells--a proposal for uniform nomenclature" 13 : 145-149, 2013

20 Chang YJ, "Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity" 12 : 631-638, 2011

21 Morita H, "Innate lymphoid cells in allergic and nonallergic inflammation" 138 : 1253-1264, 2016

22 Smith SG, "Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia" 137 : 75-86.e8, 2016

23 Zhong H, "Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis" 183 : 293-299, 2017

24 Li CW, "In vivo and in vitro studies of Th17 response to specific immunotherapy in house dust mite-induced allergic rhinitis patients" 9 : e91950-, 2014

25 박경희, "In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents" 대한천식알레르기학회 7 (7): 124-129, 2015

26 Pelly VS, "IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection" 9 : 1407-1417, 2016

27 Bartemes KR, "IL-33-responsive lineage−CD25+CD44hi lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs" 188 : 1503-1513, 2012

28 Kelly E, "IL-2 and related cytokines can promote T cell survival by activating AKT" 168 : 597-603, 2002

29 Bal SM, "IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs" 17 : 636-645, 2016

30 Bernink JH, "Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues" 14 : 221-229, 2013

31 Mjösberg JM, "Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161" 12 : 1055-1062, 2011

32 Calderón MA, "Guideline recommendations on the use of allergen immunotherapy in house dust mite allergy: Time for a change?" 140 : 41-52, 2017

33 Doherty TA, "Group 2 innate lymphoid cells: new players in human allergic diseases" 25 : 1-11, 2015

34 Melo-Gonzalez F, "Functional and phenotypic heterogeneity of group 3 innate lymphoid cells" 150 : 265-275, 2017

35 Bartemes KR, "Enhanced innate type 2 immune response in peripheral blood from patients with asthma" 134 : 671-678.e4, 2014

36 김대우, "Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine" 대한천식알레르기학회 9 (9): 299-306, 2017

37 Asaka D, "Elevated levels of interleukin-33 in the nasal secretions of patients with allergic rhinitis" 158 (158): 47-50, 2012

38 손명현, "Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis" 대한천식알레르기학회 10 (10): 1-3, 2018

39 Kuipers H, "Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization" 76 : 1028-1038, 2004

40 Krishnamoorthy N, "Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation" 194 : 863-867, 2015

41 Lombardi V, "Circulating innate lymphoid cells are differentially regulated in allergic and nonallergic subjects" 138 : 305-308, 2016

42 Gueguen C, "Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy" 137 : 545-558, 2016

43 Smarr CB, "Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases" 33 : 389-414, 2013

44 Morita H, "An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers" 43 : 175-186, 2015

45 Seehus CR, "Alternative activation generates IL-10 producing type 2 innate lymphoid cells" 8 : 1900-, 2017

46 Dachuan Fan, "Allergen-Dependent Differences in ILC2s Frequencies in Patients With Allergic Rhinitis" 대한천식알레르기학회 8 (8): 216-222, 2016

47 Doherty TA, "Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate lymphoid cells that express CD84" 133 : 1203-1205.e7, 2014

48 Marek Jutel, "Allergen Immunotherapy: Past, Present, and Future" 대한천식알레르기학회 8 (8): 191-197, 2016

49 Tham EH, "Aeroallergen sensitization and allergic disease phenotypes in Asia" 34 : 181-189, 2016

50 이지호, "A Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis" 대한천식알레르기학회 10 (10): 18-24, 2018